I suppose some will blame BTA mgmt for this.
Current BTA had nothing to do with Relenza licencing. In the industry 7%-10% is not a bad deal anywway for his type of thing.
We all know about the GSK/BTA court case. ABOBO/ peter crook keeps remionding us. Why rehash this again. WHY !!!
What good going forward does it bring. None.
- Forums
- ASX - By Stock
- BTA
- enterprise value $100m - lani superior tamiflu
enterprise value $100m - lani superior tamiflu, page-2
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online